Drug major Lupin is recalling 35,928 bottles of a generic antibiotic drug in the US market following unfavourable result in retention samples, the US health regulator said in a report.
Per the latest Enforcement Report of the US Food and Drug Administration (USFDA), the Mumbai-based company is recalling Cefdinir for oral suspension USP, 250 mg/5mL, packaged in 60 ml bottles.
The lot has been manufactured at Lupin’s Mandideep (Madhya Pradesh) manufacturing facility, and then supplied to company’s Baltimore-based arm, Lupin Pharmaceuticals Inc, which has initiated the country-wide recall on July 2.
Per the USFDA, the company ...
Read the full text thehindubusinessline